Sylvie Garneau-Tsodikova
Sylvie Garneau-Tsodikova
Professor of Pharmaceutical Sciences, University of Kentucky, Twitter @GTsodikova
Verified email at - Homepage
Cited by
Cited by
Protein posttranslational modifications: the chemistry of proteome diversifications
CT Walsh, S Garneau‐Tsodikova, GJ Gatto Jr
Angewandte Chemie International Edition 44 (45), 7342-7372, 2005
Nature's inventory of halogenation catalysts: oxidative strategies predominate
FH Vaillancourt, E Yeh, DA Vosburg, S Garneau-Tsodikova, CT Walsh
Chemical reviews 106 (8), 3364-3378, 2006
Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives
S Garneau-Tsodikova, KJ Labby
Medchemcomm 7 (1), 11-27, 2016
Biological formation of pyrroles: nature's logic and enzymatic machinery
CT Walsh, S Garneau-Tsodikova, AR Howard-Jones
Natural product reports 23 (4), 517-531, 2006
Two-peptide bacteriocins produced by lactic acid bacteria
S Garneau, NI Martin, JC Vederas
Biochimie 84 (5-6), 577-592, 2002
Robust in vitro activity of RebF and RebH, a two-component reductase/halogenase, generating 7-chlorotryptophan during rebeccamycin biosynthesis
E Yeh, S Garneau, CT Walsh
Proceedings of the National Academy of Sciences 102 (11), 3960-3965, 2005
Automated genome mining for natural products
MHT Li, PMU Ung, J Zajkowski, S Garneau-Tsodikova, DH Sherman
BMC bioinformatics 10, 1-10, 2009
The future of aminoglycosides: the end or renaissance?
JL Houghton, KD Green, W Chen, S Garneau‐Tsodikova
ChemBioChem 11 (7), 880-902, 2010
Dichlorination of a pyrrolyl-S-carrier protein by FADH2-dependent halogenase PltA during pyoluteorin biosynthesis
PC Dorrestein, E Yeh, S Garneau-Tsodikova, NL Kelleher, CT Walsh
Proceedings of the National Academy of Sciences 102 (39), 13843-13848, 2005
Isolation and Characterization of Carnocyclin A, a Novel Circular Bacteriocin Produced by Carnobacterium maltaromaticum UAL307
LA Martin-Visscher, MJ van Belkum, S Garneau-Tsodikova, RM Whittal, ...
Applied and environmental microbiology 74 (15), 4756-4763, 2008
Facile detection of acyl and peptidyl intermediates on thiotemplate carrier domains via phosphopantetheinyl elimination reactions during tandem mass spectrometry
PC Dorrestein, SB Bumpus, CT Calderone, S Garneau-Tsodikova, ...
Biochemistry 45 (42), 12756-12766, 2006
Unusual regioversatility of acetyltransferase Eis, a cause of drug resistance in XDR-TB
W Chen, T Biswas, VR Porter, OV Tsodikov, S Garneau-Tsodikova
Proceedings of the National Academy of Sciences 108 (24), 9804-9808, 2011
Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections
KJ Labby, S Garneau-Tsodikova
Future medicinal chemistry 5 (11), 1285-1309, 2013
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents
NT Chandrika, SK Shrestha, HX Ngo, S Garneau-Tsodikova
Bioorganic & medicinal chemistry 24 (16), 3680-3686, 2016
6′′‐Thioether tobramycin analogues: towards selective targeting of bacterial membranes
IM Herzog, KD Green, Y Berkov‐Zrihen, M Feldman, RR Vidavski, ...
Angewandte Chemie 124 (23), 5750-5754, 2012
Enzymatic generation of the antimetabolite γ, γ-dichloroaminobutyrate by NRPS and mononuclear iron halogenase action in a streptomycete
M Ueki, DP Galonić, FH Vaillancourt, S Garneau-Tsodikova, E Yeh, ...
Chemistry & biology 13 (11), 1183-1191, 2006
A comprehensive overview of the medicinal chemistry of antifungal drugs: perspectives and promise
KC Howard, EK Dennis, DS Watt, S Garneau-Tsodikova
Chemical Society Reviews 49 (8), 2426-2480, 2020
What are the drugs of the future?
HX Ngo, S Garneau-Tsodikova
MedChemComm 9 (5), 757-758, 2018
A combination approach to treating fungal infections
SK Shrestha, MY Fosso, S Garneau-Tsodikova
Scientific reports 5 (1), 17070, 2015
Characterization of the formation of the pyrrole moiety during clorobiocin and coumermycin A1 biosynthesis
S Garneau, PC Dorrestein, NL Kelleher, CT Walsh
Biochemistry 44 (8), 2770-2780, 2005
The system can't perform the operation now. Try again later.
Articles 1–20